NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
PHARMAZONE · NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE
Open FDA's page for this record- Application number
- ANDA220269
- Sponsor name
- PHARMAZONE
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260407
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
- Reference standard
- No
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- NITROFURANTOIN
- Strength
- 75MG
- Name
- NITROFURANTOIN, MACROCRYSTALLINE
- Strength
- 25MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA220269
- Brand name
- NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
- Generic name
- NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
- Manufacturer name
- Creekwood Pharmaceuticals LLC
- Product NDC
- 82619-147
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE
- RxCUI
- 1648755
- SPL ID
- 4f67eeb9-5a7a-3693-e063-6394a90a8655
- SPL set ID
- e47175a3-68a2-4084-9c0e-96fb057448bf
- Package NDC
- 82619-147-01, 82619-147-03, 82619-147-02
- Nui
- N0000175494, M0014892
- Pharm class epc
- Nitrofuran Antibacterial [EPC]
- Pharm class cs
- Nitrofurans [CS]
- UNII
- 927AH8112L, E1QI2CQQ1I
